NATIONAL HEALTH INVESTORS INC (NHI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
NATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, National Health Investors, Inc. (the “Company”) entered into a Change in Control Severance Agreement (
How this was made
The 30-second read
Why it matters
The filing adds a new compensation liability and may affect future earnings estimates.
Market read
Primary disclosure of a severance agreement; modest impact on valuation and compensation outlook.
What to watch
The agreement includes tax‑optimization provisions that could mitigate cash impact.
Background
National Health Investors filed an 8‑K reporting a Change in Control severance agreement with an executive, outlining cash and benefit terms.
Ticker impact
SEC Form 8‑K discloses a Change in Control severance agreement for executive Christian Maingot, detailing lump‑sum cash payments and accelerated vesting.
Potential modest downside pressure as investors assess additional severance liability.
Severance terms are material for compensation risk but unlikely to move the stock sharply.
Market effects
May signal tighter executive compensation controls in the health‑investment sector.
Limited to U.S. markets where NHI trades.
Low
Counterpoint
Investors could view the agreement as a sign of upcoming change‑of‑control activity, potentially bullish.
Key entities
- companyNational Health Investors Inc.
Issuer of the 8‑K filing.
- executiveChristian Maingot
Executive receiving the severance agreement.


